RxSight
RXST
RXST
163 hedge funds and large institutions have $235M invested in RxSight in 2026 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 62 increasing their positions, 54 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
38% less capital invested
Capital invested by funds: $382M → $235M (-$147M)
81% less call options, than puts
Call options by funds: $75K | Put options by funds: $392K
Holders
163
Holding in Top 10
1
Calls
$75K
Puts
$392K
Top Buyers
| 1 | +$8.3M | |
| 2 | +$7.32M | |
| 3 | +$5.44M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$5M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$4.46M |
Top Sellers
| 1 | -$9.51M | |
| 2 | -$5.57M | |
| 3 | -$4.13M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$3.83M |
| 5 |
Barclays
London,
United Kingdom
|
-$3.76M |
